Nov. 25, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), today announced it ranked number 452 on the Deloitte Technology Fast 500™, a ranking of the ...
The "Project Insight - Global Port Construction Projects (Q3 2024)" report has been added to ResearchAndMarkets.com's offering.This report provides a detailed analysis of port construction projects ...